Alcohol use disorder (AUD), a medical condition marked by an inability to control drinking despite harm, affects an estimated 27.9 million people in the United States.1 One of its most serious consequences is alcohol-associated liver disease (ALD), which includes a range of alcohol-related liver injury including fatty liver, hepatitis, and cirrhosis. Deaths from ALD roughly doubled between 1999 and 2022, with the sharpest acceleration in 2018 and disproportionate increases among women and adults aged 25 to 44.2 These rising harms stand in contrast to survey data showing that the share of U.S. adults who report drinking recently fell to a record-low 54%, down from 62% in 2023.3 What remains unclear is whether the incidence of newly diagnosed alcohol-attributable conditions has actually changed over the past decade, and which groups have been most affected.
We examined 196,522,676 U.S. adults aged 18 and older who received care at any point between 2016 and 2025. We tracked two groups of diagnoses, AUD and ALD. For each, we counted the first diagnosis per patient and calculated the crude annual incidence per 100,000 adults overall, by sex, and by generation as defined by birth year. Across the study period, new diagnoses of AUD and ALD rose substantially. The annual incidence of AUD climbed 36.3%, from 543.1 per 100,000 adults in 2016 to 740.5 in 2025, and ALD rose 20.6%, from 80.2 to 96.7 per 100,000, a steep relative increase from a comparatively low base (under 100 per 100,000 adults per year). Most of the increase in AUD occurred in 2023 alone: incidence was relatively stable from 2016 (543.1 per 100,000) through 2022 (577.2) and then rose 20.2% to 693.6 in 2023, a jump seen among both women and men and across every generation. Viewed across the full decade, AUD incidence rose gradually overall, dipping during the pandemic and stepping up in 2023. Part of that step-up might reflect changes in how alcohol-related conditions are coded, including revisions to the relevant diagnosis codes in late 2022, rather than true changes in incidence.
Rates for both diagnoses in men were more than double rates in women throughout the study period, but women saw larger relative increases. New AUD diagnoses increased by 42.6% among women versus 30.0% among men, and new ALD diagnoses increased by 29.2% among women versus 13.3% among men. While the relative increase was greater in women, men still saw the greater absolute increase in new diagnoses per 100,000, increasing 250.2 per 100,000 for new AUD diagnoses compared to 145.4 per 100,000 for women.
Both diagnoses rose in every generation, but in different patterns. New AUD diagnoses increased in every generation, including the oldest: up 54.3% among the Silent Generation (born 1928–1945), 32.3% among Baby Boomers (1946–1964), and roughly 30% among both Generation X (1965–1980) and Millennials (1981–1996). New ALD diagnoses, by contrast, climbed steeply in Generation X and Millennials but were flat or slightly lower in the oldest generations. Because older age is itself an established risk factor for alcohol-associated liver disease,4 much of the steep ALD increase in the younger generations likely reflects their aging into higher-risk years over the decade rather than a true rise in per-person risk. Generation Z (born 1997-2012), whose oldest members were just reaching adulthood when the study began, had the largest relative increase in AUD (56.6%); their ALD rate rose from 1.3 to 16.2 per 100,000 between 2017 and 2025 but remained uncommon.